The purpose of this study was to investigate the in vitro biocompatibility of two dental composites (namely A and B) with similar chemical composition used for direct restoration using three-dimensional confocal laser scanning microscopy (CLSM) time-lapse imaging. Time-lapse imaging was performed on cultured human HGF-1 fibroblast-like cells after staining using Live/Dead®. Image analysis showed a higher mortality rate in the presence of composite A than composite B. The viability rate decreased in a time-dependent manner during the 5 h of exposure. Morphological alterations were associated with toxic effects; cells were enlarged and more rounded in the presence of composite A as shown by F-actin and cell nuclei staining. Resazurin assay was used to confirm the active potential of composites in cell metabolism; results showed severe cytotoxic effects in the presence of both no light-curing composites after 24 h of direct contact. However, extracts of polymerized composites induced a moderate decrease in cell metabolism after the same incubation period. Composite B was significantly better tolerated than composite A at all investigated end points and all time points. The finding confirmed that the used CLSM method was sufficiently sensitive to differentiate the biocompatibility behavior of two composites based on similar methacrylate monomers.

Cultured Type II Diabetic Fibroblasts displayed no in vitro age-related changes in insulin - or serum-stimulated hexose transport. Additionally, the use of a dexamethasone amplified response protocol allowing use of near physiological concentrations of insulin (6.7 nM) also showed no in vitro age-related change in insulin-stimulated hexose transport in these cultured Type II Diabetic fibroblasts. The data indicate that Type II Diabetic fibroblasts express no differential in response to insulin or serum during aging in vitro.